title: The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.
abstract: Redox signaling is a critical component of cell signaling pathways that are involved in the regulation of cell growth, metabolism, hormone signaling, immune regulation and variety of other physiological functions. Peroxiredoxin (Prx) is a family of thiol-based peroxidase that acts as a regulator of redox signaling. Members of Prx family can act as antioxidants and chaperones. Sulfiredoxin (Srx) is an antioxidant protein that exclusively reduces over-oxidized typical 2-Cys Prx. Srx has different affinities for individual Prx and it also catalyzes the deglutathionylation of variety of substrates. Individual component of the Srx-Prx system plays critical role in carcinogenesis by modulating cell signaling pathways involved in cell proliferation, migration and metastasis. Expression levels of individual component of the Srx-Prx axis have been correlated with patient survival outcome in multiple cancer types. This review will summarize the molecular basis of differences in the affinity of Srx for individual Prx and the role of individual component of the Srx-Prx system in tumor progression and metastasis. This enhanced understanding of molecular aspects of Srx-Prx interaction and its role in cell signal transduction will help define the Srx-Prx system as a future therapeutic target in human cancer.
authors.affiliation: Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
authors.forename: Murli
authors.initials: M
authors.lastname: Mishra
authors.affiliation: Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
authors.forename: Hong
authors.initials: H
authors.lastname: Jiang
authors.affiliation: Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
authors.forename: Lisha
authors.initials: L
authors.lastname: Wu
authors.affiliation: Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
authors.forename: Hedy A
authors.initials: HA
authors.lastname: Chawsheen
authors.affiliation: Department of Toxicology and Cancer Biology, University of Kentucky College of Medicine, Lexington, KY 40536, USA; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY 40536, USA. Electronic address: qiou.wei@uky.edu.
authors.forename: Qiou
authors.initials: Q
authors.lastname: Wei
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D002471:Cell Transformation, Neoplastic / Q000378:metabolism*; D018450:Disease Progression; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D018832:Molecular Chaperones / Q000378:metabolism; D009362:Neoplasm Metastasis / Q000503:physiopathology*; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism; D050862:Oxidoreductases Acting on Sulfur Group Donors / Q000378:metabolism*; D054464:Peroxiredoxins / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology*; D013379:Substrate Specificity
chemical_list: D000975:Antioxidants; D018832:Molecular Chaperones; D010088:Oxidoreductases; D054464:Peroxiredoxins; D050862:Oxidoreductases Acting on Sulfur Group Donors; C504024:SRXN1 protein, human; D005978:Glutathione
keywords: Oncogene; Peroxiredoxin; Redox signaling; Sulfiredoxin; Tumorigenesis